DR. SAAD YOUSUF M.D. NPI 1477814960

NPI Information

  • NPI: 1477814960
  • Provider Name: DR. SAAD YOUSUF, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 600 WESTAGE BUSINESS CTR DR
    FISHKILL, NY
    ZIP 12524
  • Phone: (845) 231-5600

Map and Directions

Get Directions

NPI Details

DR. Saad Yousuf, M.D. is a hematology and oncology internal medicine in Fishkill, NY with 14 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Saad Yousuf, M.D. NPI is 1477814960. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

600 WESTAGE BUSINESS CTR DR
FISHKILL, NY
ZIP 12524-281
Phone: (845) 231-5600
Fax: (845) 231-5623

The NPI 1477814960 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Iron binding capacity (HCPCS:83550)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Folic acid level, serum (HCPCS:82746)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Magnesium level (HCPCS:83735)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Iron level (HCPCS:83540)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Vitamin d-3 level (HCPCS:82306)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Uric acid level, blood (HCPCS:84550)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Red blood count, automated test (HCPCS:85045)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Hepatitis c antibody measurement (HCPCS:86803)
  • Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
  • Hepatitis b core antibody measurement (HCPCS:86704)
  • Hepatitis b surface antibody measurement (HCPCS:86706)

The enumeration date for this NPI number is 5/31/2012 and was last updated on 3/4/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology293952NEW YORKYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.